News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
245,115 Results
Type
Article (7160)
Company Profile (43)
Press Release (237911)
Multimedia
Podcasts (16)
Webinars (7)
Section
Business (75629)
Career Advice (398)
Deals (12933)
Drug Delivery (53)
Drug Development (18882)
Employer Resources (29)
FDA (6651)
Job Trends (5314)
News (105860)
Policy (9004)
Tag
2025 Best Places to Work (6)
2026 Best Places to Work (9)
2027 BioCapital Standard (3)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (1)
2027 Biotech Beach Standard (3)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Standard (2)
40 Under 40 (1)
Academia (713)
Accelerated approval (12)
ADA (20)
Adcomms (2)
Allergies (73)
Alliances (21831)
ALS (61)
Alzheimer's disease (630)
Antibody-drug conjugate (ADC) (98)
Approvals (7093)
Artificial intelligence (517)
ASCO (38)
Autoimmune disease (103)
Automation (64)
Bankruptcy (86)
Belgium (25)
Best Places to Work (4806)
BIO (24)
Biologics (38)
BIOSECURE Act (3)
Biosimilars (149)
BioSpace Insights (47)
Biotechnology (30)
Bispecific (14)
Bladder cancer (79)
Brain cancer (25)
Breast cancer (230)
Cancer (1774)
Cardiovascular disease (171)
Career advice (355)
Career pathing (15)
CAR-T (71)
CDC (8)
CDMO (78)
Cell therapy (243)
Cervical cancer (28)
Clinical research (17393)
Collaboration (1296)
Commercialization (33)
Compensation (232)
Complete response letters (39)
COVID-19 (911)
CRISPR (46)
CRO (3)
C-suite (506)
Cystic fibrosis (37)
Data (2861)
Decentralized trials (2)
Denatured (9)
Depression (79)
Dermatology (100)
Diabetes (270)
Diagnostics (3710)
Digital health (48)
Diversity (6)
Diversity, equity & inclusion (13)
Drug discovery (173)
Drug pricing (54)
Drug shortages (8)
Duchenne muscular dystrophy (38)
Earnings (25430)
Editorial (12)
Employer branding (1)
Employer resources (29)
ESMO (58)
Events (31739)
Executive appointments (508)
Eye disease (3)
FDA (8722)
Fibrodysplasia Ossificans Progressiva (3)
Fragile X (2)
Friedreich's ataxia (2)
Frontotemporal dementia (3)
Funding (820)
Gene editing (77)
Generative AI (31)
Gene therapy (180)
GLP-1 (447)
Government (1130)
Grass and pollen (4)
Guidances (213)
Healthcare (7117)
Hematology (39)
HIV (66)
Huntington's disease (12)
Idiopathic pulmonary fibrosis (1)
IgA nephropathy (25)
Immunology and inflammation (56)
Immuno-oncology (21)
Indications (124)
Infectious disease (1056)
Inflammatory bowel disease (81)
Inflation Reduction Act (2)
Influenza (63)
Intellectual property (169)
Interviews (68)
IPO (5476)
IRA (10)
Job creations (681)
Job search strategy (272)
JPM (12)
Kidney cancer (6)
Kidney disease (21)
Labor market (19)
Layoffs (81)
Leadership (16)
Legal (1518)
Licensing (36)
Liver cancer (19)
Longevity (21)
Lung cancer (226)
Lung diease (8)
Lymphoma (128)
Machine learning (35)
Management (13)
Manufacturing (768)
Marketing (13)
MASH (34)
Medical affairs (2)
Medical device (7689)
Medtech (7911)
Melanoma (35)
Mergers & acquisitions (8272)
Metabolic disorders (600)
mRNA (85)
Multiple sclerosis (58)
Multispecific (2)
NASH (2)
Netherlands (16)
Neurodegenerative disease (162)
Neuropsychiatric disorders (19)
Neuroscience (1205)
Neurotech (1)
NextGen: Class of 2026 (2680)
Non-profit (1141)
Now hiring (15)
Obesity (282)
Opinion (95)
Ovarian cancer (40)
Pain (184)
Pancreatic cancer (109)
Parkinson's disease (131)
Partnered (25)
Patents (366)
Patient advocacy (4)
Patient recruitment (270)
Patient selection (22)
Peanut (20)
People (17913)
Peptides (24)
Pharmaceutical (10)
Pharmacy benefit managers (28)
Phase 1 (4539)
Phase 2 (7249)
Phase 3 (6752)
Pipeline (5249)
Policy (65)
Postmarket research (634)
Preclinical (1807)
Press Release (22)
Prostate cancer (101)
Psychedelics (21)
Radioligand (1)
Radiopharmaceuticals (131)
Rare diseases (352)
Real estate (2039)
Recruiting (9)
Regenerative medicine (18)
Regulatory (8828)
Reports (26)
Research institute (720)
Resumes & cover letters (60)
Rett syndrome (15)
RNA editing (6)
RSV (25)
Schizophrenia (64)
Series A (143)
Series B (88)
Service/supplier (5)
Sickle cell disease (32)
Special edition (7)
Spinal muscular atrophy (33)
Sponsored (28)
Startups (1006)
State (2)
Stem cells (1)
Stomach cancer (2)
Substance use disorders (7)
Supply chain (84)
Switzerland (5)
Tariffs (13)
The Weekly (7)
Vaccines (393)
Venture capital (24)
Weight loss (183)
Wet AMD (1)
Women's health (101)
Worklife (4)
Date
Today (33)
Last 7 days (205)
Last 30 days (1071)
Last 365 days (10405)
2026 (9515)
2025 (10593)
2024 (12796)
2023 (14398)
2022 (20981)
2021 (22516)
2020 (22170)
2019 (19148)
2018 (14086)
2017 (11770)
2016 (10888)
2015 (12372)
2014 (8814)
2013 (7304)
2012 (7871)
2011 (7719)
2010 (6514)
Location
Africa (194)
Alabama (59)
Alaska (2)
Arizona (152)
Arkansas (7)
Asia (13487)
Australia (1904)
California (4836)
Canada (1912)
China (512)
Colorado (352)
Connecticut (262)
Delaware (189)
Europe (33839)
Florida (1012)
Georgia (294)
Hawaii (2)
Idaho (45)
Illinois (758)
India (97)
Indiana (470)
Iowa (15)
Japan (259)
Kansas (93)
Kentucky (28)
Louisiana (30)
Maine (42)
Maryland (669)
Massachusetts (3077)
Michigan (226)
Minnesota (545)
Mississippi (5)
Missouri (115)
Montana (22)
Nebraska (12)
Nevada (65)
New Hampshire (52)
New Jersey (1850)
New Mexico (22)
New York (1155)
North Carolina (990)
North Dakota (11)
Northern California (2192)
Ohio (248)
Oklahoma (16)
Oregon (23)
Pennsylvania (1068)
Puerto Rico (17)
Rhode Island (29)
South America (348)
South Carolina (79)
South Dakota (1)
Southern California (2135)
Tennessee (121)
Texas (916)
United States (19930)
Utah (162)
Vermont (2)
Virginia (141)
Washington D.C. (26)
Washington State (313)
West Virginia (2)
Wisconsin (133)
Wyoming (3)
245,115 Results for "formulated solutions".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Moleculin Secures Australian Patent for Annamycin Formulation Technology
November 12, 2026
·
5 min read
Press Releases
Aspartes Pharmaceuticals Announces Successful Completion of Phase 1 Clinical Study Evaluating ASP-001 ODT Formulations
Phase 1 study supports continued development of ASP-001 toward a planned Phase 3 study in Alternating Hemiplegia of Childhood in 2027
November 12, 2026
·
1 min read
Press Releases
Channel Methods Launches MethodsSignals for Life Sciences Business Development
Formulated Solutions reports a more than 90% reduction in time from market insight to customer outreach.
August 26, 2026
·
1 min read
Press Releases
Study Shows I2Pure’s Molecular Iodine Formulations Rapidly Kill Multidrug-Resistant Pathogens without Residual Staining
October 12, 2026
·
3 min read
Press Releases
LEQEMBI® Pen (Subcutaneous Formulation of LEQEMBI®) Now Available in Japan for Patients with Early Alzheimer’s Disease
November 13, 2026
·
14 min read
Press Releases
Anixa Biosciences and Curia will Develop Final Formulation for Breast Cancer Vaccine in Preparation for Phase 2 Clinical Trial
November 18, 2026
·
5 min read
Press Releases
Olympia Pharmaceuticals Advances Longevity Offerings With Advanced Injectable CoQ10 Formulation
August 12, 2026
·
3 min read
Press Releases
Corealis Pharma and PhinC Group Collaborate to Bring Predictive Modeling into Early Formulation Development
September 23, 2026
·
2 min read
Press Releases
Meitheal Pharmaceuticals Announces FDA Approval of High-Concentration Formulation of YUSIMRY®, a Biosimilar to Humira®
September 28, 2026
·
14 min read
Press Releases
Belhaven Biopharma Initiates Pivotal Study of BBP01, a Nasal Powder Formulation of Epinephrine to Treat Anaphylaxis
October 6, 2026
·
1 min read
1 of 24,512
Next